1 to 2 of 2 literature results

• Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence.

  BACKGROUND/AIMS: HCV-related disease recurrence progresses rapidly after liver transplantation. We hypothesised that withdrawal of immunosuppression m…

  Authors: Giuseppe Tisone, Giuseppe Orlando, Andrea Cardillo, Giampiero Palmieri, Tommaso Maria Manzia, Leonardo Baiocchi, Raffaella Lionetti, Alessandro Anselmo, Luca Toti, Mario Angelico

  Source: Journal of hepatology. 2006 Apr

  View Full Text

• Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension.

  Although mycophenolate mofetil (MMF) monotherapy has been successfully used in liver transplant recipients suffering from calcineurin-inhibitor (CNI)-…

  Authors: Giuseppe Orlando, Leonardo Baiocchi, Andrea Cardillo, Giuseppe Iaria, Nicola De Liguori Carino, Nicola De Liguori, Linda De Luca, Benedetto Ielpo, Laura Tariciotti, Mario Angelico,…

  Source: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2007 Jan

  View Full Text